Though its play for Caremark appears destined to fail, the last few months have been sunny indeed for Express Scripts. Shares have soared 19% since the company unveiled the Caremark bid back on Dec. 18. The merger battle has given Express Scripts countless opportunities to criticize compensation arrangements and other matters between Caremark and CVS.